Nifty

:

24090.85

Sensex

:

76933.59

-116.90 (-0.48%)
-539.35 (-0.70%)

Login

Nifty
Sensex

:
:

24090.85
76933.59

-116.90 (-0.48%)
-539.35 (-0.70%)

Sun Pharma Advanced Research Company Ltd.

Pharmaceuticals & Drugs - Global

Rating :

75/99

BSE: 532872 | NSE: SPARC

Watchlist

NSE BSE

194.98

27-Aug-2026

Open
High
Low
Previous Close

194.69
202.38
192
194.36

Volume
Traded Value (lacs)
52 Week High
52 Week Low

811811
159412589.71
289
108

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

6,320.06
3.99
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

6,875.04
N/A
4.80

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

26.36
68.77
191.91

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
-
-

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-
-

P:E (Median)

8 Years
5 Years
3 Years

-
-
-

P:BV (Average)

8 Years
5 Years
3 Years

8.04
8.04
8.04

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-13.40
-13.40
-13.40

Earnings Forecasts:

(Updated: 22-08-2026)

Description 2026 2027 2028 2029
Adj EPS 40 34 - -
P/E Ratio 4.87 5.73 - -
Revenue - - - -
EBITDA - - - -
Net Income - - - -
ROA - - - -
P/B Ratio - - - -
ROE - - - -
FCFF - - - -
FCFF Yield - - - -
Net Debt - - - -
BVPS - - - -

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var%
Net Sales 39.92 9.64 314.11% 1,853.22 27.19 6,715.81% 8.45 14.91 -43.33% 7.86 12.86 -38.88%
Expenses 74.23 61.97 19.78% 80.28 81.11 -1.02% 65.32 89.29 -26.85% 73.75 116.71 -36.81%
EBITDA -34.31 -52.33 - 1,772.94 -53.92 - -56.87 -74.38 - -65.89 -103.85 -
EBIDTM -85.95% -542.84% 95.67% -198.31% -673.02% -498.86% -838.30% -807.54%
Other Income 23.66 9.02 162.31% 1.80 0.00 0 0.00 0.19 -100.00% 0.01 0.04 -75.00%
Interest 8.13 6.18 31.55% 11.64 4.51 158.09% 8.78 2.77 216.97% 7.52 1.11 577.48%
Depreciation 2.20 2.54 -13.39% 2.40 2.55 -5.88% 2.56 2.75 -6.91% 2.57 2.77 -7.22%
PBT -20.98 -52.03 - 1,760.70 -60.98 - -80.57 -79.71 - -75.97 -107.69 -
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT -20.98 -52.03 - 1,760.70 -60.98 - -80.57 -79.71 - -75.97 -107.69 -
PATM -52.56% -539.73% 95.01% -224.27% -953.49% -534.61% -966.54% -837.40%
EPS -0.65 -1.60 - 54.26 -1.88 - -2.48 -2.46 - -2.34 -3.32 -

Description Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var%
Net Sales 39.92 9.64 314.11% 1,853.22 27.19 6,715.81% 8.45 14.91 -43.33% 7.86 12.86 -38.88%
Expenses 73.92 61.72 19.77% 80.02 80.37 -0.44% 65.09 88.60 -26.53% 73.58 115.77 -36.44%
EBITDA -34.00 -52.08 - 1,773.20 -53.18 - -56.64 -73.69 - -65.72 -102.91 -
EBIDTM -85.17% -540.25% 95.68% -195.59% -670.30% -494.23% -836.13% -800.23%
Other Income 23.66 9.14 158.86% 1.80 0.00 0 0.00 0.19 -100.00% 0.01 0.04 -75.00%
Interest 8.13 6.19 31.34% 11.64 4.54 156.39% 8.78 2.80 213.57% 7.52 1.14 559.65%
Depreciation 2.20 2.68 -17.91% 2.40 2.95 -18.64% 2.57 3.14 -18.15% 2.56 3.16 -18.99%
PBT -20.67 -51.81 - 1,760.96 -60.67 - -80.35 -79.44 - -75.79 -107.17 -
Tax 0.11 0.06 83.33% -0.38 -0.90 - 0.07 0.07 0.00% 0.06 0.16 -62.50%
PAT -20.78 -51.87 - 1,761.34 -59.77 - -80.42 -79.51 - -75.85 -107.33 -
PATM -52.05% -538.07% 95.04% -219.82% -951.72% -533.27% -965.01% -834.60%
EPS -0.64 -1.60 - 54.28 -1.84 - -2.48 -2.45 - -2.34 -3.31 -

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Net Sales 1,909.45 1,879.17 71.77 75.55 238.78 137.25 252.96 76.81 182.87 78.26 181.02 Net Sales Growth 2,855.80% 2518.32% -5.00% -68.36% 73.97% -45.74% 229.33% -58.00% 133.67% -56.77% Cost Of Goods Sold 26.13 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Gross Profit 1,883.32 1,879.17 71.77 75.55 238.78 137.25 252.96 76.81 182.87 78.26 181.02 GP Margin 98.63% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% Total Expenditure 293.58 281.31 399.04 479.34 452.84 324.00 387.93 386.83 334.16 320.87 303.72 Power & Fuel Cost - 6.26 6.33 6.14 5.75 4.62 4.60 5.14 5.08 4.92 4.67 % Of Sales - 0.33% 8.82% 8.13% 2.41% 3.37% 1.82% 6.69% 2.78% 6.29% 2.58% Employee Cost - 101.85 108.96 118.53 107.00 98.31 91.59 93.09 81.06 100.92 84.30 % Of Sales - 5.42% 151.82% 156.89% 44.81% 71.63% 36.21% 121.20% 44.33% 128.95% 46.57% Manufacturing Exp. - 56.00 114.52 140.23 180.31 134.27 209.78 30.47 17.81 31.79 29.39 % Of Sales - 2.98% 159.57% 185.61% 75.51% 97.83% 82.93% 39.67% 9.74% 40.62% 16.24% General & Admin Exp. - 105.46 164.48 207.41 154.91 84.39 78.49 251.32 221.40 181.18 180.29 % Of Sales - 5.61% 229.18% 274.53% 64.88% 61.49% 31.03% 327.20% 121.07% 231.51% 99.60% Selling & Distn. Exp. - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 % Of Sales - 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% Miscellaneous Exp. - 11.72 4.75 7.03 4.87 2.41 3.48 6.81 8.80 2.05 0.00 % Of Sales - 0.62% 6.62% 9.31% 2.04% 1.76% 1.38% 8.87% 4.81% 2.62% 2.80% EBITDA 1,615.87 1,597.86 -327.27 -403.79 -214.06 -186.75 -134.97 -310.02 -151.29 -242.61 -122.70 EBITDA Margin 84.62% 85.03% -456.00% -534.47% -89.65% -136.07% -53.36% -403.62% -82.73% -310.01% -67.78% Other Income 25.47 10.83 1.79 29.47 10.88 6.84 5.41 9.76 13.51 4.94 13.72 Interest 36.07 34.12 8.91 1.66 7.63 13.33 10.65 2.67 0.09 0.12 1.82 Depreciation 9.73 10.07 10.83 12.13 11.77 10.16 10.92 9.48 7.55 8.18 8.24 PBT 1,583.18 1,564.50 -345.22 -388.11 -222.58 -203.40 -151.14 -312.40 -145.43 -245.97 -119.04 Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Rate 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% PAT 1,583.18 1,552.13 -345.22 -388.11 -222.58 -203.40 -151.14 -312.40 -145.43 -197.00 -119.04 PAT before Minority Interest 1,583.18 1,552.13 -345.22 -388.11 -222.58 -203.40 -151.14 -312.40 -145.43 -197.00 -119.04 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 82.91% 82.60% -481.01% -513.71% -93.22% -148.20% -59.75% -406.72% -79.53% -251.73% -65.76% PAT Growth 627.01% - - - - - - - - - EPS 48.79 47.83 -10.64 -11.96 -6.86 -6.27 -4.66 -9.63 -4.48 -6.07 -3.67

Description TTM Mar 26 Mar 25 Mar 24 Mar 23
Net Sales 1,909.45 1,879.17 71.77 75.55 238.78 Net Sales Growth 2,855.80% 2518.32% -5.00% -68.36% Cost Of Goods Sold 26.13 0.00 0.00 0.00 0.00 Gross Profit 1,883.32 1,879.17 71.77 75.55 238.78 GP Margin 98.63% 100% 100% 100% 100% Total Expenditure 292.61 280.40 394.90 477.64 452.84 Power & Fuel Cost - 6.26 6.33 6.14 5.75 % Of Sales - 0.33% 8.82% 8.13% 2.41% Employee Cost - 118.02 153.58 141.84 107.00 % Of Sales - 6.28% 213.99% 187.74% 44.81% Manufacturing Exp. - 56.00 114.52 140.23 180.31 % Of Sales - 2.98% 159.57% 185.61% 75.51% General & Admin Exp. - 88.01 115.92 182.20 154.91 % Of Sales - 4.68% 161.52% 241.16% 64.88% Selling & Distn. Exp. - 0.00 0.00 0.00 0.00 % Of Sales - 0% 0% 0% 0% Miscellaneous Exp. - 12.11 4.55 7.23 4.87 % Of Sales - 0.64% 6.34% 9.57% 2.04% EBITDA 1,616.84 1,598.77 -323.13 -402.09 -214.06 EBITDA Margin 84.68% 85.08% -450.23% -532.22% -89.65% Other Income 25.47 10.95 1.79 29.47 10.88 Interest 36.07 34.13 9.04 1.69 7.63 Depreciation 9.73 10.21 12.39 12.51 11.77 PBT 1,584.15 1,565.37 -342.78 -386.83 -222.58 Tax -0.14 -0.19 -0.27 0.38 0.00 Tax Rate -0.01% -0.01% 0.08% -0.10% 0.00% PAT 1,584.29 1,553.20 -342.51 -387.21 -222.58 PAT before Minority Interest 1,584.29 1,553.20 -342.51 -387.21 -222.58 Minority Interest 0.00 0.00 0.00 0.00 0.00 PAT Margin 82.97% 82.65% -477.23% -512.52% -93.22% PAT Growth 630.79% - - - EPS 48.82 47.86 -10.56 -11.93 -6.86

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Shareholder's Funds 1,333.59 -220.62 124.86 512.78 31.23 -168.25 -18.64 296.24 184.72 158.16 Share Capital 32.45 32.45 32.45 32.45 27.19 26.21 26.21 26.21 25.09 24.69 Total Reserves 1,301.13 -253.07 92.40 480.32 -230.22 -194.46 -44.84 270.03 67.96 133.47 Non-Current Liabilities 77.58 176.17 117.59 138.41 77.43 164.59 55.85 7.20 11.98 10.36 Secured Loans 0.00 0.00 0.00 0.00 0.00 112.50 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 100.00 0.00 0.00 0.00 0.00 6.38 1.09 1.64 2.18 Long Term Provisions 12.34 7.68 6.05 8.14 8.15 8.63 10.23 6.11 10.34 8.18 Current Liabilities 756.83 373.72 243.89 178.95 171.43 233.35 235.36 95.04 116.11 108.03 Trade Payables 106.31 124.40 149.82 148.25 72.19 91.17 158.84 82.92 102.48 94.45 Other Current Liabilities 83.75 85.40 43.52 24.15 93.96 56.44 11.20 7.66 9.42 9.81 Short Term Borrowings 556.14 158.19 47.00 0.05 0.00 80.00 60.00 0.00 0.10 0.41 Short Term Provisions 10.63 5.74 3.55 6.49 5.28 5.75 5.31 4.46 4.10 3.35 Total Liabilities 2,168.00 329.27 486.34 830.14 280.09 229.69 272.57 398.48 312.81 276.55 Net Block 85.32 95.33 102.65 105.75 91.87 90.56 103.86 57.56 51.74 69.16 Gross Block 143.99 152.70 151.87 146.22 133.15 122.51 135.50 80.22 67.17 77.28 Accumulated Depreciation 58.67 57.37 49.22 40.47 41.28 31.95 31.64 22.66 15.44 8.12 Non Current Assets 306.61 304.02 239.93 375.16 208.93 166.58 205.38 141.09 137.59 118.27 Capital Work in Progress 71.71 54.15 43.79 27.00 26.37 5.23 32.07 24.13 3.27 1.47 Non Current Investment 0.43 0.42 0.42 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 120.63 128.19 67.67 64.80 67.83 70.64 69.24 59.29 82.48 47.45 Other Non Current Assets 28.52 25.93 25.40 177.61 22.87 0.15 0.20 0.12 0.10 0.19 Current Assets 1,861.38 25.26 246.41 454.96 71.15 59.80 67.19 257.38 175.22 158.28 Current Investments 0.00 0.00 1.80 290.90 11.66 6.43 8.49 210.58 107.57 9.65 Inventories 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Sundry Debtors 8.27 16.06 15.53 32.71 27.74 17.58 16.05 10.17 17.56 38.90 Cash & Bank 0.32 1.19 155.06 111.58 1.23 9.31 0.46 0.68 1.32 70.31 Other Current Assets 1,852.79 4.14 19.58 3.98 30.52 26.49 42.19 35.96 48.77 39.43 Short Term Loans & Adv. 9.55 3.88 54.43 15.80 28.02 21.70 39.33 33.39 46.73 37.48 Net Current Assets 1,104.55 -348.46 2.52 276.02 -100.28 -173.55 -168.17 162.34 59.11 50.25 Total Assets 2,167.99 329.28 486.34 830.12 280.08 226.38 272.57 398.47 312.81 276.55

Description Mar 26 Mar 25 Mar 24 Mar 23
Shareholder's Funds 1,338.83 -216.95 125.76 512.78 Share Capital 32.45 32.45 32.45 32.45 Total Reserves 1,306.37 -249.40 93.30 480.32 Non-Current Liabilities 75.68 175.93 122.97 138.41 Secured Loans 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 100.00 0.00 0.00 Long Term Provisions 12.34 7.68 6.05 8.14 Current Liabilities 754.11 374.24 265.06 178.95 Trade Payables 97.15 113.92 142.29 148.25 Other Current Liabilities 87.96 94.24 61.88 24.15 Short Term Borrowings 556.14 158.19 47.00 0.05 Short Term Provisions 12.85 7.89 13.89 6.49 Total Liabilities 2,168.62 333.22 513.79 830.14 Net Block 85.32 98.76 107.53 105.75 Gross Block 143.99 158.11 157.14 146.22 Accumulated Depreciation 58.67 59.35 49.60 40.47 Non Current Assets 306.18 307.03 244.39 375.16 Capital Work in Progress 71.71 54.15 43.79 27.00 Non Current Investment 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 120.63 128.19 67.67 64.80 Other Non Current Assets 28.52 25.93 25.40 177.61 Current Assets 1,862.43 26.20 269.39 454.96 Current Investments 0.00 0.00 1.80 290.90 Inventories 0.00 0.00 0.00 0.00 Sundry Debtors 8.27 16.06 15.53 32.71 Cash & Bank 1.16 1.96 155.33 111.58 Other Current Assets 1,853.00 4.20 42.24 3.98 Short Term Loans & Adv. 9.72 3.98 54.48 15.80 Net Current Assets 1,108.32 -348.04 4.33 276.02 Total Assets 2,168.61 333.23 513.78 830.12

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Cash From Operating Activity -238.89 -362.41 -429.43 -69.12 -208.23 -151.90 -210.81 -171.91 -182.77 -128.04 PBT 1,552.13 -345.22 -388.11 -222.58 -203.40 -151.14 -312.40 -145.43 -245.97 -119.04 Adjustment 41.14 18.83 -11.33 6.99 16.67 48.75 9.44 -21.77 3.82 -1.14 Changes in Working Capital -1,863.80 -46.80 -25.88 141.11 -26.05 -47.88 102.02 -0.17 20.48 12.86 Cash after chg. in Working capital -270.53 -373.20 -425.32 -74.48 -212.78 -150.26 -200.95 -167.38 -221.68 -107.32 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 31.64 10.79 -4.11 5.37 4.54 -1.63 -9.86 -4.54 -10.08 -20.72 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 48.98 0.00 Cash From Investing Activity -23.51 157.66 391.11 -548.28 -29.17 1.56 155.35 -102.19 -104.62 -6.61 Net Fixed Assets -8.85 -11.19 -22.44 -13.70 -31.78 39.83 -63.22 -33.91 8.31 28.94 Net Investments -0.01 1.80 288.68 -279.24 -5.23 2.06 202.09 -103.01 -97.92 -9.65 Others -14.65 167.05 124.87 -255.34 7.84 -40.33 16.48 34.73 -15.01 -25.90 Cash from Financing Activity 261.53 200.88 42.80 616.76 229.32 159.28 55.46 274.25 224.01 194.25 Net Cash Inflow / Outflow -0.87 -3.87 4.48 -0.64 -8.08 8.95 0.00 0.15 -63.38 59.60 Opening Cash & Equivalents 1.19 5.06 0.58 1.22 9.30 0.35 0.35 0.20 63.58 4.00 Closing Cash & Equivalent 0.32 1.19 5.06 0.58 1.22 9.30 0.35 0.35 0.20 63.58

Description Mar 26 Mar 25 Mar 24 Mar 23
Cash From Operating Activity -238.78 -360.29 -429.19 -69.12 PBT 1,553.01 -342.78 -386.83 -222.58 Adjustment 41.16 20.52 -10.91 6.99 Changes in Working Capital -1,864.59 -46.86 -27.33 141.11 Cash after chg. in Working capital -270.42 -369.12 -425.08 -74.48 Interest Paid 0.00 0.00 0.00 0.00 Tax Paid 31.64 8.83 -4.11 5.37 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 Cash From Investing Activity -23.50 157.66 391.53 -548.28 Net Fixed Assets -8.85 -11.19 -22.44 Net Investments -0.01 1.80 288.68 Others -14.64 167.05 125.29 Cash from Financing Activity 261.39 199.26 42.41 616.76 Net Cash Inflow / Outflow -0.89 -3.38 4.74 -0.64 Opening Cash & Equivalents 1.96 5.33 0.58 1.22 Closing Cash & Equivalent 1.16 1.96 5.33 0.58

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Book Value (Rs.) 41.09 -6.80 3.85 15.80 -7.47 -6.42 -0.71 11.30 3.71 6.41 ROA 124.31% -84.65% -58.96% -40.10% -79.80% -60.18% -93.11% -40.89% -66.85% -53.72% ROE 278.92% 0.00% -121.73% -143.72% 0.00% 0.00% -225.08% -74.72% -156.84% -127.40% ROCE 164.61% -321.18% -112.88% -69.44% -225.57% -254.10% -178.95% -59.95% -113.05% -94.66% Fixed Asset Turnover 12.67 0.47 0.51 1.71 1.07 1.96 0.71 2.48 1.08 1.97 Receivable days 2.36 80.33 116.55 46.20 60.25 24.26 62.28 27.67 131.66 48.45 Inventory Days 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Payable days 0.00 0.00 0.00 0.00 0.00 0.00 316.55 300.15 244.72 218.01 Cash Conversion Cycle 2.36 80.33 116.55 46.20 60.25 24.26 -254.27 -272.48 -113.05 -169.56 Total Debt/Equity 0.42 -1.17 0.38 0.00 -0.37 -1.37 -3.59 0.01 0.02 0.02 Interest Cover 46.48 -37.76 -233.48 -28.15 -14.26 -13.19 -115.79 -1547.78 -1596.71 -64.41

Description Mar 26 Mar 25 Mar 24 Mar 23
Book Value (Rs.) 41.25 -6.68 3.88 15.80 ROA 124.17% -80.88% -57.63% -26.81% ROE 276.89% 0.00% -121.28% -43.41% ROCE 163.94% -311.92% -112.35% -41.91% Fixed Asset Turnover 12.44 0.46 0.50 1.63 Receivable days 2.36 80.33 116.55 50.01 Inventory Days 0.00 0.00 0.00 0.00 Payable days 0.00 0.00 0.00 0.00 Cash Conversion Cycle 2.36 80.33 116.55 50.01 Total Debt/Equity 0.42 -1.19 0.37 0.00 Interest Cover 46.50 -36.92 -227.27 -28.15

Top Investors:

sun pharmaceutical industries key employees benefit trust

lakshdeep investments & finance (p) ltd.

vijay mohanlal parekh

paresh mohanlal parekh

enam securities private limited

Annual Reports:

News Update:

Sun Pharma Adv. Res - Quarterly Results
11th Aug 2026, 00:00 AM

Read More
SPARC’s licensing partner receives Complete Response Letter from USFDA
20th May 2026, 12:00 PM

Ocuvex Therapeutics Inc. has received a Complete Response Letter for the PDP-716 New Drug Application
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback